Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Grand Hyatt Washington at Washington Center

Feb 20, 2013 8:00 AM - Feb 21, 2013 5:00 PM

1000 H Street, NW, , Washington, DC 20001-4310 , USA

Marketing Pharmaceuticals 2013: Workshop for Regulatory, Legal, Communications Professionals, and Promotional Review Teams

Recent Updates and Future Trends in Corporate Integrity Agreements and Compliance Programs

Session Chair(s)

John T. Murray

John T. Murray

President

Grayscale Compliance LLC, United States

Leading legal and compliance professionals will discuss the most recent Corporate Integrity Agreements and future trends in compliance programs. The panel will also discuss the recent decision from the U.S. Court of Appeals in case of the U.S. v. Caronia which represents a landmark challenge to FDA in its approach to regulating off-label promotion. The panel will discuss what it may or may not mean for FDA-regulated companies and their compliance programs.

Speaker(s)

William A. Sarraille, JD

Speakers

William A. Sarraille, JD

Sidley Austin, LLP, United States

Partner

Kris  Curry, MBA

Speakers

Kris Curry, MBA

Johnson & Johnson, United States

Vice President, Pharmaceuticals Group Health Care Compliance

Kathleen  Meriwether

Speakers

Kathleen Meriwether

Ernst and Young, United States

Principal, Assurance Services - Fraud Investigation and Dispute Services

Doug H. Hallward-Driemeier

Speakers

Doug H. Hallward-Driemeier

Ropes and Gray, LLP, United States

Partner

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.